Detecting risky behaviors in agitated, bedridden neurosurgery patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a pilot observational project conducted in the neurosurgery department at CHU Clermont-Ferrand that will continuously observe bedridden patients who display agitation or confusion. Eligible patients are those hospitalized at least nine days with neurological or cognitive disorders leading to agitation, and participation requires patient or trusted-person consent. Observers will document the nature and frequency of risk behaviors and related events such as use of physical or chemical restraints, falls, and required additional examinations. The collected descriptive data aim to clarify patterns of endangerment for patients and emotional and economic impacts for caregivers and the hospital.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Hospitalized in the Neurosurgery Department of the Clermont-Ferrand University Hospital
* Suffering from neurological and/or cognitive disorders leading to agitation and/or confusion
* Affiliation to a social security system
* Hospitalization in the department for at least 9 days
* Acceptance by the patient and/or trusted person capable of giving informed consent to participate in the research

Exclusion Criteria:

* Acute or transient agitation phase of somatic origin (bladder globe, pain, ionic disorder...)
* Patient under guardianship, curatorship or safeguard of justice
* Pregnant and breastfeeding women
* Refusal to participate

Where it's running

• CHU clermont-ferrand
  Clermont-Ferrand, France Recruiting

Study contacts

• Principal investigator: Charlène DUBOIS — University Hospital, Clermont-Ferrand
• Study coordinator: Lise Laclautre
• Email: promo_interne_drci@chu-clermontferrand.fr
• Phone: 334.73.754.963

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Virtual nature vs guided imagery for anxiety and well-being in hospitalized older adults

  In this study, hospitalized adults 65 and older try two ways to bring nature to them: watching 360-degree nature videos on a VR headset or listening to a guided imagery audio to imagine the same scenes, to see which helps mood and anxiety during a two-week period.

  Recruiting at 2 sites Semmelweis University · Budapest and 1 other locations · NCT07765355

• PARO robotic seal to reduce agitation after visceral surgery

  This trial tests whether interacting with PARO, a social robotic seal, reduces postoperative agitation in adults having elective visceral surgery.

  Recruiting Hannover Medical School · Hanover, Lower Saxony · NCT07568093

• Daily Screen Time and Postoperative Delirium in Children (2–11) After Lower Abdominal Surgery

  This study tests whether how much a child uses screens daily is linked to the child’s emergence delirium in the first 30 minutes after waking up from anesthesia.

  Recruiting Kanuni Sultan Suleyman Training and Research Hospital · Istanbul, Istanbul · NCT07552896

• Effects of a fasting-mimicking 5-day program and a Longevity Diet on age-related risk factors and aging biomarkers

  This trial will test whether a 5-day fasting-mimicking diet, alone or combined with a Longevity Diet, helps improve body weight, body composition, cardiovascular risk markers, and aging-related biomarkers in adults aged 30–65, many of whom are overweight or have metabolic risk.

  Recruiting Fondazione Valter Longo · Varapodio, Calabria, Italy · NCT07255300

• Improving interchangeability of reference materials and quality controls for laboratory tests

  This project tests whether specially made reference materials and quality controls behave like real patient samples on automated lab machines for adults, including people taking certain immunosuppressant medicines.

  Recruiting University Hospital, Montpellier · Montpellier and 1 other locations · NCT07173114

• Long-term KarXT plus KarX-EC treatment for agitation in Alzheimer’s disease

  This will test whether taking KarXT together with KarX-EC reduces agitation and is safe long-term in people with Alzheimer’s disease who completed the earlier parent studies.

  Recruiting at 58 sites Phase 3 Bristol-Myers Squibb · Chandler, Arizona and 251 other locations · NCT06937229

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.